COMPASS PATHWAYS PLC Operating Cash Flow
COMPASS PATHWAYS PLC (CMPS) reported Operating Cash Flow of -$88.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$40.31M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$47.94M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$37.79M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$35.11M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for fiscal 2025 was -$157.24M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for fiscal 2024 was -$119.19M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for fiscal 2023 was -$97.38M.
- COMPASS PATHWAYS PLC net cash provided by (used in) operating activities for fiscal 2022 was -$105.45M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$40.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$88.24M 10-Q · filed 2026-08-05 | -$126.03M derived: sum of 3 quarters · filed 2026-08-05 | -$161.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$47.94M 10-Q · filed 2026-05-13 | -$85.72M derived: sum of 2 quarters · filed 2026-05-13 | -$120.83M derived: sum of 3 quarters · filed 2026-05-13 | -$159.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$37.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$72.89M derived: sum of 2 quarters · filed 2026-03-24 | -$111.58M derived: sum of 3 quarters · filed 2026-08-05 | -$157.24M 10-K · filed 2026-03-24 |
| 2025-09-30 | -$35.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$73.80M derived: sum of 2 quarters · filed 2026-08-05 | -$119.45M 10-Q · filed 2025-11-04 | -$161.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$38.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$84.35M 10-Q · filed 2026-08-05 | -$126.10M derived: sum of 3 quarters · filed 2026-08-05 | -$148.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$45.66M 10-Q · filed 2026-05-13 | -$87.41M derived: sum of 2 quarters · filed 2026-05-13 | -$109.60M derived: sum of 3 quarters · filed 2026-05-13 | -$144.01M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$41.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$63.94M derived: sum of 2 quarters · filed 2026-03-24 | -$98.36M derived: sum of 3 quarters · filed 2026-03-24 | -$119.19M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$22.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$56.60M derived: sum of 2 quarters · filed 2025-11-04 | -$77.43M 10-Q · filed 2025-11-04 | -$105.21M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$34.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$55.24M 10-Q · filed 2025-07-31 | -$83.03M derived: sum of 3 quarters · filed 2025-07-31 | -$100.08M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$20.83M 10-Q · filed 2025-05-08 | -$48.61M derived: sum of 2 quarters · filed 2025-05-08 | -$65.67M derived: sum of 3 quarters · filed 2025-05-08 | -$90.48M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$27.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$44.84M derived: sum of 2 quarters · filed 2025-02-27 | -$69.65M derived: sum of 3 quarters · filed 2025-02-27 | -$97.38M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$17.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$41.87M derived: sum of 2 quarters · filed 2024-10-31 | -$69.59M 10-Q · filed 2024-10-31 | -$114.90M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | -$24.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$52.54M 10-Q · filed 2024-08-01 | -$97.84M derived: sum of 3 quarters · filed 2024-08-01 | -$116.86M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$27.72M 10-Q · filed 2024-05-08 | -$73.03M derived: sum of 2 quarters · filed 2024-05-08 | -$92.05M derived: sum of 3 quarters · filed 2024-05-08 | -$110.05M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$45.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$64.32M derived: sum of 2 quarters · filed 2024-02-29 | -$82.33M derived: sum of 3 quarters · filed 2024-02-29 | -$105.45M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$19.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$37.03M derived: sum of 2 quarters · filed 2023-11-02 | -$60.15M 10-Q · filed 2023-11-02 | -$82.52M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$41.13M 10-Q · filed 2023-08-03 | -$63.50M derived: sum of 3 quarters · filed 2024-02-29 | -$77.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$23.12M 10-Q · filed 2023-05-11 | -$45.49M derived: sum of 2 quarters · filed 2024-02-29 | -$59.39M derived: sum of 3 quarters · filed 2024-02-29 | -$77.09M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$22.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$36.26M derived: sum of 2 quarters · filed 2024-02-29 | -$53.97M derived: sum of 3 quarters · filed 2024-02-29 | -$67.75M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$13.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$31.60M derived: sum of 2 quarters · filed 2022-11-03 | -$45.38M 10-Q · filed 2022-11-03 | -$62.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$17.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$31.48M 10-Q · filed 2022-08-04 | -$48.23M derived: sum of 3 quarters · filed 2023-02-28 | -$62.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$13.78M 10-Q · filed 2022-05-10 | -$30.53M derived: sum of 2 quarters · filed 2023-02-28 | -$44.44M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$16.75M derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | -$30.67M derived: sum of 2 quarters · filed 2023-02-28 | -$41.38M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$13.91M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | -$24.63M 6-K · filed 2021-11-09 | ||
| 2020-06-30 | -$10.71M 6-K · filed 2021-08-11 | |||
| 2019-12-31 | -$17.81M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |